FDA Inspection 1226729 — Mid-Missouri Reproductive Med & Srgry Inc
The FDA completed an inspection of Mid-Missouri Reproductive Med & Srgry Inc on Dec 6, 2023 in Columbia, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 6, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Columbia, MO (United States)